The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

ICH M7(R2) Assessment and Control of DNA reactive (mutagenic) Impurities in Pharmaceuticals to limit potential carcinogenic risk

Short Title:

Document Type:
ICH Guideline
This guideline emphasizes considerations of both safety and quality risk management in establishing levels of mutagenic impurities

Go back

GMP Conferences by Topics